Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19

NCT04428801 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: autologous adipose-derived stem cells

Sponsor

Celltex Therapeutics Corporation